Assessment of cardiomyocyte size and the expression of hypertrophic genes, including ANP, BNP and β-MHC, demonstrated that MG53 knockdown reversed the protective effect of AK045171 on cardiac hypertrophy induced by Ang II treatment (Figure 5I, 5J). Here, NPPB is linked to cardiac hypertrophy.